These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 35864970)

  • 1. Novel insights into m
    Jia J; Wu S; Jia Z; Wang C; Ju C; Sheng J; He F; Zhou M; He J
    Int J Biol Sci; 2022; 18(11):4432-4451. PubMed ID: 35864970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the reciprocal regulation of m
    Yang J; Liang F; Zhang F; Zhao H; Gong Q; Gao N
    Pharmacol Ther; 2024 Jul; 259():108671. PubMed ID: 38830387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into the interplay between m
    Yi YC; Chen XY; Zhang J; Zhu JS
    Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression.
    Wei L; Liu S; Xie Z; Tang G; Lei X; Yang X
    Int Immunopharmacol; 2024 Oct; 140():112824. PubMed ID: 39116490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA m
    Wang Z; Zhou J; Zhang H; Ge L; Li J; Wang H
    Mol Oncol; 2023 Feb; 17(2):195-229. PubMed ID: 36260366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Zhou Y; Jian N; Jiang C; Wang J
    Biomed Pharmacother; 2024 Oct; 179():117331. PubMed ID: 39191030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Huang H; Weng H; Chen J
    Cancer Cell; 2020 Mar; 37(3):270-288. PubMed ID: 32183948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between N
    Chen Y; Lin Y; Shu Y; He J; Gao W
    Mol Cancer; 2020 May; 19(1):94. PubMed ID: 32443966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs: the new central dogma of cancer biology.
    Saw PE; Xu X; Chen J; Song EW
    Sci China Life Sci; 2021 Jan; 64(1):22-50. PubMed ID: 32930921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
    Meng Q; Schatten H; Zhou Q; Chen J
    Aging (Albany NY); 2023 Jul; 15(13):6577-6619. PubMed ID: 37437245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the cross-talk between N6-methyladenosine modification and non-coding RNAs in breast cancer: Mechanisms and clinical implications.
    Liu X; Xie X; Sui C; Liu X; Song M; Luo Q; Zhan P; Feng J; Liu J
    Int J Cancer; 2024 Jun; 154(11):1877-1889. PubMed ID: 38429857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer.
    Liu M; Zhang S; Zhou H; Hu X; Li J; Fu B; Wei M; Huang H; Wu H
    Theranostics; 2023; 13(8):2616-2631. PubMed ID: 37215575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.
    Wen T; Li T; Xu Y; Zhang Y; Pan H; Wang Y
    Cell Commun Signal; 2023 Dec; 21(1):355. PubMed ID: 38102645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of the hidden coding information in cancers: Mechanisms and biological functions.
    Zhou X; Wu X; Lai K; Zhou R; Chen Z; Yang Z; Gao X
    Int J Cancer; 2023 Jul; 153(1):20-32. PubMed ID: 36408913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing and Chemical Modifications on Non-Coding RNAs in Cancer: A New Tale with Clinical Significance.
    Torsin LI; Petrescu GED; Sabo AA; Chen B; Brehar FM; Dragomir MP; Calin GA
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers.
    Xu Y; Yu X; Guo W; He Y
    Front Immunol; 2023; 14():1129298. PubMed ID: 36875073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current research advances of the relationship between non-coding RNAs and tumor].
    Li K; Guo J; Xiao B; Zhou H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):56-9. PubMed ID: 20140869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New understandings of the genetic regulatory relationship between non-coding RNAs and m
    Liu S; Xiang D
    Front Genet; 2023; 14():1270983. PubMed ID: 38125749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.